MAPT and Alzheimer disease: Notably, activating cAMP pathways—and therefore PKA—was shown to be protective against Tau aggregation and toxicity in Tau transgenic mice53, whereas a reduced abundance of 14-3-3 proteins in AD brains46,54 may indirectly promote the intraneuronal aggregation of highly phosphorylated Tau typical for the disease.